Gupta Nitin, Kumari Samta, Vias Poorva, Kaur Manpreet, Verma Shalini
Department of Nuclear medicine, Dr Rajendra Prasad Government medical college,Tanda Kangra Himachal Pradesh, India.
Department of Nuclear medicine, Shree Balaji superspeciality hospital, Kangra Himachal Pradesh, India.
Asia Ocean J Nucl Med Biol. 2025;13(1):21-32. doi: 10.22038/aojnmb.2024.76461.1536.
F-FDG PET/CT has been used to characterize the primary lesion and staging in head and neck cancers (HNC). However, prior studies for detecting distant metastasis and synchronous tumors are sparse, especially in Indian context. To investigate the frequency and distribution of head and neck carcinomas, distant metastases and synchronous malignancies detected in HNC in a north Indian population.
Medical records and whole body F-FDG PET/CT examinations performed for initial staging on a total of 281 newly diagnosed HNC patients between 01/2019 to 31/6/2023 in North India were retrospectively analyzed and reviewed to look for distant metastasis and synchronous tumors.
On whole body F-FDG PET/CT, distant metastases were detected in 33 (11.7%) patients, all with locally advanced primary tumors corresponding to T category 3 and 4. Lung (6%) and bone (~6.7%) were the most common sites of distant metastasis. In nine patients metastases were detected below the diaphragm. Synchronous malignancies were discovered and histopathologically proven in 22 (7%) patients. Lung carcinoma was the most common synchronous tumor, detected in 9 patients. In seven patients synchronous tumour was detected outside the aerodigestive tract, of which four were below the diaphragm.
Of the distant metastasis diagnosed in 11.7% of HNC patients with TNM tumor category T3 and T4, 3% of metastasis lesions were detected below the diaphragm. Synchronous malignancy was diagnosed in 7% patients irrespective of primary HNC stage. These findings demonstrate the advantage of using whole body F-FDG PET/CT as an ideal and preferred modality for initial staging and screening of HNC patients since detection of distant metastasis or a synchronous malignancy changes the management approach in these patients.
氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(F-FDG PET/CT)已用于头颈部癌(HNC)的原发灶特征描述及分期。然而,此前关于检测远处转移和同步性肿瘤的研究较少,尤其是在印度背景下。本研究旨在调查印度北部人群中HNC患者的头颈部癌、远处转移及同步性恶性肿瘤的发生频率和分布情况。
回顾性分析并审查了2019年1月1日至2023年6月31日期间在印度北部对281例新诊断的HNC患者进行初始分期时的病历及全身F-FDG PET/CT检查结果,以寻找远处转移和同步性肿瘤。
在全身F-FDG PET/CT检查中,33例(11.7%)患者检测到远处转移,所有患者的原发肿瘤均为局部晚期,对应T分类为3级和4级。肺(6%)和骨(约6.7%)是最常见的远处转移部位。9例患者的转移灶位于膈肌以下。22例(7%)患者发现并经组织病理学证实存在同步性恶性肿瘤。肺癌是最常见的同步性肿瘤,9例患者中检测到肺癌。7例患者的同步性肿瘤位于气道消化道外,其中4例位于膈肌以下。
在TNM肿瘤分类为T3和T4的HNC患者中,11.7%被诊断为远处转移,其中3%的转移灶位于膈肌以下。7%的患者被诊断为同步性恶性肿瘤,与HNC原发灶分期无关。这些发现表明,使用全身F-FDG PET/CT作为HNC患者初始分期和筛查的理想且首选方式具有优势,因为检测到远处转移或同步性恶性肿瘤会改变这些患者的治疗方法。